{'fraction_non_alphanumeric': 0.024608501118568233, 'fraction_numerical': 0.009507829977628635, 'mean_word_length': 5.82824427480916, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Lipopolysaccharide‐evoked activation of p38 and JNK leads to an increase in ICAM‐1 expression in Schwann cells of sciatic nerves

Lipopolysaccharide is a major constituent of the outer membrane of Gram‐negative bacteria. It activates monocytes and macrophages to produce cytokines such as tumor necrosis factor‐α and interleukins IL‐1β and IL‐6. These cytokines appear to be responsible for the neurotoxicity observed in peripheral nervous system inflammatory disease. It has been reported that, in the central nervous system, the expression level of intercellular adhesion molecule‐1 (ICAM‐1) was dramatically upregulated in response to LPS, as well as many inflammatory cytokines. ICAM‐1 contributes to multiple processes seen in central nervous system inflammatory disease, for example migration of leukocytes to inflammatory sites, and adhesion of polymorphonuclear cells and monocytes to central nervous system cells. In the present study, we found that lipopolysacharide evoked ICAM‐1 mRNA and protein expression early at 1 h post‐injection, and the most significant increase was seen at 4 h. Immunofluorescence double‐labeling suggested that most of the ICAM‐1‐positive staining was located in Schwann cells. Using Schwann cell cultures, we demonstrated that ICAM‐1 expression in Schwann cells is regulated by mitogen‐activated protein kinases, especially the p38 and stress‐activated protein kinase/c‐Jun N‐terminal kinase pathways. Thus, it is thought that upregulation of ICAM‐1 expression in Schwann cells may be important for host defenses after peripheral nervous system injury, and reducing the biosynthesis of ICAM‐1 and other cytokines by blocking the cell signal pathway might provide a new strategy against inflammatory and immune reaction after peripheral nerve injury.